The DOI matches its Crossref record.
Increased expression of programmed death (PD)‐1 and its ligand PD‐L1 correlates with impaired cell‐mediated immunity in high‐risk human papillomavirus‐related cervical intraepithelial neoplasia
Open accessAbstract
Summary: Impaired local cellular immunity contributes to the pathogenesis of persistent high‐risk human papillomavirus (HR‐HPV) infection and related cervical intraepithelial neoplasia (CIN), but the underlying molecular mechanisms remain unclear. Recently, the programmed death 1/programmed death 1 ligand (PD‐1/PD‐L 1; CD 279/CD 274) pathway was demonstrated to play a critical role in attenuating T‐cell responses and promoting T‐cell tolerance during chronic viral infections. In this study, we examined the expression of PD‐1 and PD‐L 1 on cervical T cells and dendritic cells (DC s), respectively, from 40 women who were HR‐HPV‐negative (−) or HR‐HPV‐positive (+) with CIN grades 0, I and II–III. We also measured interferon‐γ, interleukin‐12 (IL‐12) and IL‐10 in cervical exudates. The most common HPV type was HPV 16, followed by HPV 18, 33, 51 and 58. PD‐1 and PD‐L 1 expression on cervical T cells and DC s, respectively, was associated with HR‐HPV positivity and increased in parallel with increasing CIN grade. The opposite pattern was observed for CD 80 and CD 86 expression on DC s, which decreased in HR‐HPV(+) patients in parallel with increasing CIN grade. Similarly, reduced levels of the T helper type 1 cytokines interferon‐γ and IL‐12 and increased levels of the T helper type 2 cytokine IL‐10 in cervical exudates correlated with HR‐HPV positivity and CIN grade. Our results suggest that up‐regulation of the inhibitory PD‐1/PD‐L1 pathway may negatively regulate cervical cell‐mediated immunity to HPV and contribute to the progression of HR‐HPV‐related CIN. These results may aid in the development of PD‐1/PD‐L 1 pathway‐based strategies for immunotherapy of HR‐HPV‐related CIN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study
Audirac-Chalifour, A., Torres-Poveda, K., Bahena-Román, M., Téllez-Sosa, J., Martínez-Barnetche, J., Cortina-Ceballos, B., López-Estrada, G., Delgado-Romero, K., Burguete-García, A. I., Cantú, D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153274 · Cited by 400
Wang, X., Li, J., Dong, K., Lin, F., Long, M., Ouyang, Y., Wei, J., Chen, X., Weng, Y., He, T., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2014.12.003 · Cited by 313
Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
Saleh, R., & Elkord, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.017 · Cited by 292
Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
Mezache, L., Paniccia, B., Nyinawabera, A., & Nuovo, G. J. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.108 · Cited by 311
Heeren, A. M., Punt, S., Bleeker, M. C., Gaarenstroom, K. N., van der Velden, J., Kenter, G. G., de Gruijl, T. D., & Jordanova, E. S. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.64 · Cited by 310
Metadata
- Authors
- Yang, W., Song, Y., Lu, Y., Sun, J., & Wang, H.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2013-07-02
- Volume
- 139
- Issue
- 4
- Pages
- 513-522
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W1986104642
- Cited by
- 205
- References
- 0
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased expression of programmed death (PD)‐1 and its ligand PD‐L1 correlates with impaired cell‐mediated immunity in high‐risk human papillomavirus‐related cervical intraepithelial neoplasia. https://app.cochat.ai/papers/10.1111/imm.12101
- The paper
- Yang, W., Song, Y., Lu, Y., Sun, J., & Wang, H. (2013). Increased expression of programmed death (PD)‐1 and its ligand PD‐L1 correlates with impaired cell‐mediated immunity in high‐risk human papillomavirus‐related cervical intraepithelial neoplasia. Immunology. https://doi.org/10.1111/imm.12101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.